Brief: PacBio Announces Private Convertible Exchange Transaction Of $441 Mln Principal Amount Of 1.375% Convertible Senior Notes Due 2030
26/06/2023 11:05
June 26 (Reuters) - Pacific Biosciences of California
Inc PACB.O :
* PACBIO ANNOUNCES A PRIVATE CONVERTIBLE EXCHANGE
TRANSACTION OF
$441 MILLION PRINCIPAL AMOUNT OF 1.375% CONVERTIBLE SENIOR NOTES
DUE 2030
* PACIFIC BIOSCIENCES OF CALIFORNIA INC-IN EXCHANGE FOR
ISSUING
NEW NOTES PURSUANT TO EXCHANGE TRANSACTION, CO WILL RECEIVE,
CANCEL EXCHANGED 2028 NOTES
Source text for Eikon: ID:nPn8B4Sm7a
Further company coverage: PACB.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Pacific Biosciences of California
See all newsBrief: Pacbio And Verily Health Announce Multi-Year Strategic Collaboration
Pacific Biosciences of California, Inc. reports results for the quarter ended June 30 - Earnings Summary
Pacific Biosciences Q2 adj. loss bigger than estimates on margin pressure
Brief: Pacific Biosciences of California Q2 EPS USD -0.14
Pacific Biosciences of California Inc expected to post a loss of 13 cents a share - Earnings Preview